Source link : https://newshealth.biz/health-news/promising-response-data-for-menin-inhibitor-in-relapsed-refractory-aml/
(MedPage Today) — HOUSTON — Complete response (CR) rates in relapsed/refractory NPM1-mutated acute myeloid leukemia (AML) doubled historical rates in a preliminary study of an investigational menin inhibitor. A pooled analysis of data from… Source link : https://www.medpagetoday.com/meetingcoverage/soho/117333 Author : Publish date : 2025-09-05 18:48:00 Copyright for syndicated content belongs to the linked Source.
The post Promising Response Data for Menin Inhibitor in Relapsed/Refractory AML first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-05 18:48:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8